Cloning of Syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis.
about
Yellow fever virus infection in Syrian golden hamsters: relationship between cytokine expression and pathologic changesCoating doxorubicin-loaded nanocapsules with alginate enhances therapeutic efficacy against Leishmania in hamsters by inducing Th1-type immune responsesIdentification of small molecule lead compounds for visceral leishmaniasis using a novel ex vivo splenic explant model systemLeishmania donovani triose phosphate isomerase: a potential vaccine target against visceral leishmaniasisCharacterization of glycolytic enzymes--rAldolase and rEnolase of Leishmania donovani, identified as Th1 stimulatory proteins, for their immunogenicity and immunoprophylactic efficacies against experimental visceral leishmaniasisEvaluation of Leishmania donovani protein disulfide isomerase as a potential immunogenic protein/vaccine candidate against visceral LeishmaniasisDuplex real-time reverse transcriptase PCR to determine cytokine mRNA expression in a hamster model of New World cutaneous leishmaniasis.Nucleosomal histone proteins of L. donovani: a combination of recombinant H2A, H2B, H3 and H4 proteins were highly immunogenic and offered optimum prophylactic efficacy against Leishmania challenge in hamsters.Host cytokine production, lymphoproliferation, and antibody responses during the course of Ancylostoma ceylanicum infection in the Golden Syrian hamster.Animal models for the study of leishmaniasis immunology.Clinical and experimental advances in treatment of visceral leishmaniasis.Gender is a major determinant of the clinical evolution and immune response in hamsters infected with Leishmania sppProgressive visceral leishmaniasis is driven by dominant parasite-induced STAT6 activation and STAT6-dependent host arginase 1 expression.Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy.Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis.Parasite burden in hamsters infected with two different strains of leishmania (Leishmania) infantum: "Leishman Donovan units" versus real-time PCR.Comparative evaluation of lesion development, tissue damage, and cytokine expression in golden hamsters (Mesocricetus auratus) infected by inocula with different Leishmania (Viannia) braziliensis concentrations.Transcriptional profiling of the spleen in progressive visceral leishmaniasis reveals mixed expression of type 1 and type 2 cytokine-responsive genes.Leishmania donovani infection induces anemia in hamsters by differentially altering erythropoiesis in bone marrow and spleenProinflammatory and immunomodulatory cytokine mRNA time course profiles in hamsters infected with a virulent variant of Leptospira interrogans.Validation of assays to monitor immune responses in the Syrian golden hamster (Mesocricetus auratus).Immunosuppression in hamsters with progressive visceral leishmaniasis is associated with an impairment of protein kinase C activity in their lymphocytes that can be partially reversed by okadaic acid or anti-transforming growth factor beta antibodyRecombinant NAD-dependent SIR-2 protein of Leishmania donovani: immunobiochemical characterization as a potential vaccine against visceral leishmaniasis.Animal models for the analysis of immune responses to leishmaniasis.Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis.Compartmentalized Immune Response in Leishmaniasis: Changing Patterns throughout the DiseaseTranscriptional Profiling in Experimental Visceral Leishmaniasis Reveals a Broad Splenic Inflammatory Environment that Conditions Macrophages toward a Disease-Promoting Phenotype.Immunogenicity of the P-8 amastigote antigen in the experimental model of canine visceral leishmaniasis.Development of real-time PCR assays for evaluation of immune response and parasite load in golden hamster (Mesocricetus auratus) infected by Leishmania (Viannia) braziliensis.DNA vaccination with KMP11 and Lutzomyia longipalpis salivary protein protects hamsters against visceral leishmaniasisImmunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B-encapsulated nanoemulsion template-based chitosan nanocapsules.Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters.Immunoprotective responses of T helper type 1 stimulatory protein-S-adenosyl-L-homocysteine hydrolase against experimental visceral leishmaniasis.Photodynamic vaccination of hamsters with inducible suicidal mutants of Leishmania amazonensis elicits immunity against visceral leishmaniasis.Head-to-head comparison of three vaccination strategies based on DNA and raw insect-derived recombinant proteins against Leishmania.An assessment of the genetic diversity of Leishmania infantum isolates from infected dogs in BrazilReal-time reverse transcription-PCR quantification of cytokine mRNA expression in golden Syrian hamster infected with Leishmania infantum and treated with a new amphotericin B formulation.Designing therapies against experimental visceral leishmaniasis by modulating the membrane fluidity of antigen-presenting cells.
P2860
Q27486499-2BB176F9-1A09-4381-8A91-FFF17E61356BQ28383050-42E6B758-60D4-4A6C-93CA-E459593BC03EQ28477163-79E04F15-FD9A-4A6E-9BC8-488E51EA843EQ28483976-415F760E-991B-432D-887A-6F2EF8D06591Q28539119-5A4573B7-DA2F-47B2-9586-B822BD42F8D1Q31060208-5C2DA339-F57D-403A-82AC-1AD427F1FB54Q33612946-9DC1652E-61CD-41E1-8E3C-186AAC4D9182Q33753259-813CC5ED-D38A-4088-A71E-6F9F48658487Q33788299-0A6195B2-7D6F-4DBE-A113-770FE3695543Q33859617-2C5DD4EE-E9F9-4253-B0AA-6AC5F1446FB5Q33982648-D492A528-5455-4182-AD9D-5580D6F40D72Q34121668-CF33017F-47D2-437A-A646-692227805E53Q34139938-4C9FA67F-3E0C-4C39-89BC-D22B5F3E85D3Q34181985-D656B5CC-FC41-4D51-9EEF-B9623A3FEF29Q34277331-68CB34A3-74FE-44A3-860A-7AE1FFFE1F87Q34462414-F84EA91F-8A34-475F-AB1B-5E0EDC76C326Q34595909-0884619E-D5BC-49D9-901A-275AB19F00A8Q34617155-7AF9446C-E421-4428-8ECE-DAAB78F61C3EQ34637852-1AF67121-71A1-4C63-BDC6-A3E5617A8F30Q34721459-952FCC1A-0F5D-41D6-9C3A-08CB6B246027Q34900058-8CA30E78-D78B-461B-AC30-193B1E2B8482Q34934364-AF200CAD-2167-49B1-9EBC-929104CE679BQ35154482-640559A4-1A1B-4AA0-A41A-345619889B2CQ35188674-EC32505D-5AEA-4A5C-85B0-AB8D6F53BC01Q35702943-A6D29169-6001-4A4D-984B-213CDEA9F58EQ36015750-A96B3135-E831-4A87-806A-9D898E1358B1Q36265092-B72D5CE7-6DC0-4A54-BD6A-CC3FAFC9B136Q36945381-6A7F2AD2-183B-413C-9C92-A5F63CA26E5FQ37045346-A70B93D3-18F5-429A-B50E-47D67A4C5F44Q37106270-F540A656-47CF-4706-8008-8575C01545AEQ39203200-A18F3F38-079D-4662-BD30-339BEB82C94AQ40101284-D1E3A5FE-04E9-4985-BCFC-519CCA6DD3D2Q40783439-43F29187-1BC8-4311-B1BB-CBB58DB23771Q41383476-A3C831F0-B9F6-4E54-9D39-703A9B6C1905Q41404819-A63745F0-7737-46CD-B33F-6C32FFEFEC37Q41981494-BA1BAB7D-6C74-4EA5-9292-B25DF7A36BDAQ42112456-4060F380-0CD4-4AB6-910B-6840DF3B1912Q43121720-32E3A936-C284-46F4-B46E-32990D0E0329
P2860
Cloning of Syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Cloning of Syrian hamster (Mes ...... mental visceral leishmaniasis.
@en
Cloning of Syrian hamster
@nl
type
label
Cloning of Syrian hamster (Mes ...... mental visceral leishmaniasis.
@en
Cloning of Syrian hamster
@nl
prefLabel
Cloning of Syrian hamster (Mes ...... mental visceral leishmaniasis.
@en
Cloning of Syrian hamster
@nl
P2093
P2860
P1476
Cloning of Syrian hamster (Mes ...... imental visceral leishmaniasis
@en
P2093
B Chandrasekar
G L Freeman
P2860
P304
P407
P577
1998-05-01T00:00:00Z